Literature DB >> 26765098

Outcomes of vascular intervention and use of perioperative medications for nonpulmonary aneurysms in Behçet disease.

Qi Liu1, Wei Ye1, Changwei Liu2, Yongjun Li1, Rong Zeng1, Leng Ni1.   

Abstract

BACKGROUND: Aneurysms attributable to Behçet disease (BD) are not common but are associated with a poor prognosis because of a high risk of rupture. Special considerations are required for vascular intervention, because the intense local inflammation may increase complications. The aim of this study was to assess the outcome of operative intervention and the use of perioperative medical therapy for aneurysms in patients with BD.
MATERIALS AND METHODS: We reviewed retrospectively the medical records of patients with BD admitted to Peking Union Medical College Hospital between January 1995 and January 2015.
RESULTS: Among 874 patients diagnosed with BD, 176 patients had vascular involvement, of whom 59 had arterial aneurysms. Thirty-six patients with 51 arterial aneurysms underwent operative intervention. The 51 primary operative interventions included 20 open operations and 31 endovascular interventions. Eleven (22 %) recurrent aneurysms developed in 10 patients and 5 (10%) thrombosis occurred in 5 patients. Of the 19 endovascular stents placed for aortic aneurysms, 1 type I endoleak, 1 graft occlusion, 3 recurrent aneurysms, and 1 recurrent aneurysmal rupture occurred. Among the revascularization procedures for extremity arteries, there were more complications with endovascular intervention than with open surgery. The cumulative risk of recurrent aneurysmal formation at the operative site was significantly less in patients treated with operative intervention combined with use of immunosuppressants than those treated with operative intervention alone (P = .01).
CONCLUSION: In patients with BD, an endovascular approach is feasible and effective for aortic aneurysms, whereas bypass surgery appears to provide better outcomes for extremity arterial aneurysms than placement of endovascular stents. The administration of corticosteroids combined with cyclophosphamide perioperatively decreases the cumulative risk of recurrent aneurysm.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26765098     DOI: 10.1016/j.surg.2015.11.022

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Successful management of a giant dissecting aortic aneurysm in a patient with Behcet's disease.

Authors:  Zhiqi Zhang; Kanhua Yin; Yi Lin; Changfa Guo; Yongxin Sun; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Clinical characteristics and radiographic outcomes of vascular Behçet's disease involving the aorta or its major branches.

Authors:  Seulkee Lee; Seonyoung Kang; Yeonghee Eun; Hyungjin Kim; Jaejoon Lee; Eun-Mi Koh; Duk-Kyung Kim; Hoon-Suk Cha
Journal:  Clin Rheumatol       Date:  2022-02-07       Impact factor: 2.980

3.  Serum uric acid could be served as an independent marker for increased risk and severity of ascending aortic dilatation in Behçet's disease patients.

Authors:  Jianfei Cai; Yinjia Zhang; Jun Zou; Yan Shen; Dan Luo; Huafang Bao; Yong Chen; Jingfen Ye; Jian-Long Guan
Journal:  J Clin Lab Anal       Date:  2018-08-12       Impact factor: 2.352

Review 4.  Behcet's disease with recurrent thoracic aortic aneurysm combined with femoral artery aneurysm: a case report and literature review.

Authors:  Shi-Huai Zhang; Fu-Xian Zhang
Journal:  J Cardiothorac Surg       Date:  2017-09-06       Impact factor: 1.637

5.  Behçet Syndrome and Crohn's Disease: What Are the Differences?

Authors:  Bernardo Baptista; Natália Marto; João Galaz Tavares; Alexandra Bayão Horta; Diogo Cunha E Sá; Gonçalo Gerardo; Manuela Mafra
Journal:  Eur J Case Rep Intern Med       Date:  2019-03-01

Review 6.  Coronary Involvement in Behçet's Disease: what are its Risks and Prognosis? (Rare Cases and Literature Review).

Authors:  Unsal Vural; Mehmet Kizilay; Ahmet Arif Aglar
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01

7.  Behcet's disease involved the root of aorta in the treatment with modified Bentall procedure: a case report.

Authors:  Zeyi Cheng; Zhefeng Kang; Yupeng Ji; Yingqiang Guo
Journal:  J Cardiothorac Surg       Date:  2020-01-29       Impact factor: 1.637

8.  Management of tibioperoneal trunk aneurysm in a patient with Behçet disease.

Authors:  Mohammed Hamouda; Hanaa Dakour Aridi; Rachel Elizabeth Lee; Jasninder Singh Dhaliwal; Mahmoud B Malas
Journal:  J Vasc Surg Cases Innov Tech       Date:  2017-12-27

9.  The Diagnosis and Management of Vasculo-Behçet's Disease.

Authors:  Ryusuke Yoshimi
Journal:  Intern Med       Date:  2018-08-24       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.